Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases

Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases

Objective: The evolution of non-vitamin K antagonist anticoagulants (NOACs) has changed the horizon of stroke prevention in atrial fibrillation (SPAF). All 4 NOACs have been tested against dose-adjusted warfarin in well-designed, pivotal, phase III, randomized, controlled trials (RCTs) and were appr...

Full description

Bibliographic Details
Main Authors: Uğur Önsel Türk, Rezzan Deniz Acar, Taylan Akgün, Volkan Emren, Selçuk Kanat, Emir Karacağlar, Alper Kepez, Şeref Kul, Erdem Özel, Evrim Şimşek, Selcen Yakar Tülüce, Kamil Tülüce, A. John Camm
Format: Article
Language:English
Published: KARE Publishing 2020-04-01
Series:Türk Kardiyoloji Derneği Arşivi
Subjects:
atrial fibrillation
non-vitamin k antagonist oral anticoagulant
real life
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-16359

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-16359

Similar Items